Major depression following smoking cessation - PubMed (original) (raw)
Major depression following smoking cessation
L S Covey et al. Am J Psychiatry. 1997 Feb.
Abstract
Objective: The authors examined the incidence and predictors of major depression following successful smoking cessation treatment, with special attention to the influence of past major depression.
Method: Three-month follow-up data were obtained from 126 subjects who successfully completed a 10-week smoking cessation program.
Results: The 3-month incidence of new major depression following treatment for nicotine dependence was 2%, 17%, and 30% among subjects with histories of no major depression, single major depression, and recurrent major depression, respectively. A history of major depression and persistent withdrawal symptoms independently predicted posttreatment major depression.
Conclusions: Continued patient care beyond the 2-4-week period associated with the nicotine withdrawal syndrome is indicated when abstinence is attempted by smokers with prior major depression.
Similar articles
- Development of major depression after treatment for smoking cessation.
Tsoh JY, Humfleet GL, Muñoz RF, Reus VI, Hartz DT, Hall SM. Tsoh JY, et al. Am J Psychiatry. 2000 Mar;157(3):368-74. doi: 10.1176/appi.ajp.157.3.368. Am J Psychiatry. 2000. PMID: 10698811 - Nicotine withdrawal in smokers with current depressive disorders undergoing intensive smoking cessation treatment.
Blalock JA, Robinson JD, Wetter DW, Schreindorfer LS, Cinciripini PM. Blalock JA, et al. Psychol Addict Behav. 2008 Mar;22(1):122-8. doi: 10.1037/0893-164X.22.1.122. Psychol Addict Behav. 2008. PMID: 18298238 Clinical Trial. - Depression after smoking cessation: case reports.
Stage KB, Glassman AH, Covey LS. Stage KB, et al. J Clin Psychiatry. 1996 Oct;57(10):467-9. doi: 10.4088/jcp.v57n1005. J Clin Psychiatry. 1996. PMID: 8909333 - [Depression and smoking].
Aubin HJ, Tilikete S, Barrucand D. Aubin HJ, et al. Encephale. 1996 Jan-Feb;22(1):17-22. Encephale. 1996. PMID: 8681871 Review. French. - Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships.
Morissette SB, Tull MT, Gulliver SB, Kamholz BW, Zimering RT. Morissette SB, et al. Psychol Bull. 2007 Mar;133(2):245-72. doi: 10.1037/0033-2909.133.2.245. Psychol Bull. 2007. PMID: 17338599 Review.
Cited by
- History of single episode and recurrent major depressive disorder among smokers in cessation treatment: Associations with depressive symptomatology and early cessation failure.
Cohn AM, Strong DR, Abrantes AM, Brown RA. Cohn AM, et al. Addict Disord Their Treat. 2010 Mar 1;9(1):41-52. doi: 10.1097/ADT.0b013e3181b91c6b. Addict Disord Their Treat. 2010. PMID: 20228875 Free PMC article. - Smoking and the Five-Factor Model of personality.
Terracciano A, Costa PT Jr. Terracciano A, et al. Addiction. 2004 Apr;99(4):472-81. doi: 10.1111/j.1360-0443.2004.00687.x. Addiction. 2004. PMID: 15049747 Free PMC article. - Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent.
Dwoskin LP, Rauhut AS, King-Pospisil KA, Bardo MT. Dwoskin LP, et al. CNS Drug Rev. 2006 Fall-Winter;12(3-4):178-207. doi: 10.1111/j.1527-3458.2006.00178.x. CNS Drug Rev. 2006. PMID: 17227286 Free PMC article. Review. - Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers.
Marx CE, Trost WT, Shampine L, Behm FM, Giordano LA, Massing MW, Rose JE. Marx CE, et al. Psychopharmacology (Berl). 2006 Jun;186(3):462-72. doi: 10.1007/s00213-005-0226-x. Epub 2006 Jan 10. Psychopharmacology (Berl). 2006. PMID: 16402195 - E-Cigarettes for Immediate Smoking Substitution in Women Diagnosed with Cervical Dysplasia and Associated Disorders.
James SA, Meier EM, Wagener TL, Smith KM, Neas BR, Beebe LA. James SA, et al. Int J Environ Res Public Health. 2016 Mar 4;13(3):288. doi: 10.3390/ijerph13030288. Int J Environ Res Public Health. 2016. PMID: 26959042 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous